Daniele Castiglia

Dr. Daniele Castiglia

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2014 in Human Molecular Genetics
Verified
Journal Article
Closed access
TOTeresa Odorisio
Teresa Odorisio
MSMichela Di Salvio
Michela Di Salvio
AOAngela Orecchia
Angela Orecchia
GZGiovanni Di Zenzo
Giovanni Di Zenzo
EPEugenia Piccinni
Eugenia Piccinni
DCDaniele Castiglia
Daniele Castiglia
Recessive dystrophic epidermolysis bullosa (RDEB) is a genodermatosis characterized by fragile skin forming blisters that heal invariably with scars. It is due to mutations in the COL7A1 gene encoding type VII collagen, the major component of anchoring fibrils connecting the cutaneous basement membrane to the dermis. Identical COL7A1 mutations often result in inter- and intra-familial disease variability, suggesting that additional modifiers contribute to RDEB course. Here, we studied a monozygotic twin pair with RDEB presenting markedly different phenotypic manifestations, while expressing similar amounts of collagen VII. Genome-wide expression analysis in twins' fibroblasts showed differential expression of genes associated with TGF-β pathway inhibition. In particular, decorin, a skin matrix component with anti-fibrotic properties, was found to be more expressed in the less affected twin. Accordingly, fibroblasts from the more affected sibling manifested a profibrotic and contractile phenotype characterized by enhanced α-smooth muscle actin and plasminogen activator inhibitor 1 expression, collagen I release and collagen lattice contraction. These cells also produced increased amounts of proinflammatory cytokines interleukin 6 and monocyte chemoattractant protein-1. Both TGF-β canonical (Smads) and non-canonical (MAPKs) pathways were basally more activated in the fibroblasts of the more affected twin. The profibrotic behaviour of these fibroblasts was suppressed by decorin delivery to cells. Our data show that the amount of type VII collagen is not the only determinant of RDEB clinical severity, and indicate an involvement of TGF-β pathways in modulating disease variability. Moreover, our findings identify decorin as a possible anti-fibrotic/inflammatory agent for RDEB therapeutic intervention.

Verified
Journal Article
Open access
PDF file
ACAngelo Giuseppe Condorelli
Angelo Giuseppe Condorelli
EDElena Dellambra
Elena Dellambra
ELElena Logli
Elena Logli
GZGiovanna Zambruno
Giovanna Zambruno
DCDaniele Castiglia
Daniele Castiglia
Epidermolysis bullosa (EB) is a heterogeneous group of inherited skin disorders determined by mutations in genes encoding for structural components of the cutaneous basement membrane zone. Disease hallmarks are skin fragility and unremitting blistering. The most disabling EB (sub)types show defective wound healing, fibrosis and inflammation at lesional skin. These features expose patients to serious disease complications, including the development of cutaneous squamous cell carcinomas (SCCs). Almost all subjects affected with the severe recessive dystrophic EB (RDEB) subtype suffer from early and extremely aggressive SCCs (RDEB-SCC), which represent the first cause of death in these patients. The genetic determinants of RDEB-SCC do not exhaustively explain its unique behavior as compared to low-risk, ultraviolet-induced SCCs in the general population. On the other hand, a growing body of evidence points to the key role of tumor microenvironment in initiation, progression and spreading of RDEB-SCC, as well as of other, less-investigated, EB-related SCCs (EB-SCCs). Here, we discuss the recent advances in understanding the complex series of molecular events (i.e., fibrotic, inflammatory, and immune processes) contributing to SCC development in EB patients, cross-compare tumor features in the different EB subtypes and report the most promising therapeutic approaches to counteract or delay EB-SCCs.

1 November 2017 in Matrix Biology
Verified
Journal Article
Closed access
LGLiliana Guerra
Liliana Guerra
TOTeresa Odorisio
Teresa Odorisio
GZGiovanna Zambruno
Giovanna Zambruno
DCDaniele Castiglia
Daniele Castiglia

1 August 2006 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
PDF file
CHCristina Has
Cristina Has
VWVesarat Wessagowit
Vesarat Wessagowit
MPMonica Pascucci
Monica Pascucci
CBCorinna Baer
Corinna Baer
BDBiagio Didona
Biagio Didona
DCDaniele Castiglia
Daniele Castiglia

9 February 2015 in Human Mutation
Verified
Journal Article
Closed access
PDF file
AMAndrea Dal Mas
Andrea Dal Mas
PFPaola Fortugno
Paola Fortugno
IDIrving Donadon
Irving Donadon
LLLauretta Levati
Lauretta Levati
DCDaniele Castiglia
Daniele Castiglia
FPFranco Pagani
Franco Pagani

1 September 2001 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
DCDaniele Castiglia
Daniele Castiglia
PPPatrizia Posteraro
Patrizia Posteraro
MPMari Pinola
Mari Pinola
GZGiovanna Zambruno
Giovanna Zambruno
FSFlavia Spirito
Flavia Spirito
GMGuerrino Meneguzzi
Guerrino Meneguzzi